DrugMar 1, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 50 microgram/mL recall — FDA D-0338-2023
Subpotent Drug
Class IIFDA: TerminatedIBSA PHARMA Inc.
Latest records
Latest recalls — page 320
The newest recall records with useful source details are listed here.
DrugMar 1, 2023
Dermoplast FIRST AID ANTIBACTERIAL SPRAY recall — FDA D-0329-2023
Subpotent Drug: Low assay observed in one of the two active ingredients during stability testing.
Class IIIFDA: TerminatedAdvantice Health, LLC
DrugMar 1, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 44 microgram/mL recall — FDA D-0337-2023
Subpotent Drug
Class IIFDA: TerminatedIBSA PHARMA Inc.
DrugMar 1, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 13 microgram/mL recall — FDA D-0331-2023
Subpotent Drug
Class IIFDA: TerminatedIBSA PHARMA Inc.
DrugMar 1, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 100 microgram/mL recall — FDA D-0332-2023
Subpotent Drug
Class IIFDA: TerminatedIBSA PHARMA Inc.
DrugMar 1, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 88 microgram/mL recall — FDA D-0341-2023
Subpotent Drug
Class IIFDA: TerminatedIBSA PHARMA Inc.
DrugMar 1, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 125 microgram/mL recall — FDA D-0333-2023
Subpotent Drug
Class IIFDA: TerminatedIBSA PHARMA Inc.
DrugMar 1, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 37.5 microgram/mL recall — FDA D-0336-2023
Subpotent Drug
Class IIFDA: TerminatedIBSA PHARMA Inc.
DrugMar 1, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 112 microgram/mL recall — FDA D-0342-2023
Subpotent Drug
Class IIFDA: TerminatedIBSA PHARMA Inc.
DrugMar 1, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 175 microgram/mL recall — FDA D-0334-2023
Subpotent Drug
Class IIFDA: TerminatedIBSA PHARMA Inc.
DrugMar 1, 2023
Tacrolimus Capsules, USP, 0.5 mg, 100-count bottle recall — FDA D-0330-2023
Presence of Foreign Tablets/Capsules: Presence of one Tacrolimus 1 mg capsule co-mingled in a bottle containing and labeled as Tacrolimus 0.5 mg capsules.
Class IIFDA: OngoingDr. Reddy's Laboratories, Inc.
DrugMar 1, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 62.5 microgram/mL recall — FDA D-0339-2023
Subpotent Drug
Class IIFDA: TerminatedIBSA PHARMA Inc.
DrugMar 1, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 150 microgram/mL recall — FDA D-0344-2023
Subpotent Drug
Class IIFDA: TerminatedIBSA PHARMA Inc.
DrugMar 1, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 75 microgram/mL recall — FDA D-0340-2023
Subpotent Drug
Class IIFDA: TerminatedIBSA PHARMA Inc.
DrugMar 1, 2023
SODIUM CHLORIDE 0.9% Sodium Chloride Injection, USP, 1000 mL Excel Plus Container recall — FDA D-0346-2023
Lack of sterility assurance: Recall of certain batches of 0.9% Sodium Chloride for Injection USP in EXCEL Plus IV Container product due to the possibility of an incomplete seal that may…
Class IIFDA: CompletedB. Braun Medical Inc.
DrugMar 1, 2023
SODIUM CHLORIDE 0.9% Sodium Chloride Injection, USP, 500 mL Excel Plus Container recall — FDA D-0347-2023
Lack of sterility assurance: Recall of certain batches of 0.9% Sodium Chloride for Injection USP in EXCEL Plus IV Container product due to the possibility of an incomplete seal that may…
Class IIFDA: CompletedB. Braun Medical Inc.
DrugMar 1, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 137 microgram/mL recall — FDA D-0343-2023
Subpotent Drug
Class IIFDA: TerminatedIBSA PHARMA Inc.
DrugMar 1, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 200 microgram/mL recall — FDA D-0345-2023
Subpotent Drug
Class IIFDA: TerminatedIBSA PHARMA Inc.
VehicleFeb 27, 2023
Model Y critical fasteners recall — NHTSA campaign 23V130000
Tesla, Inc. (Tesla) is recalling certain 2022-2023 Model Y vehicles. The bolts securing the second-row seat back frames may not have been securely tightened.
critical fastenersTesla, Inc.
VehicleFeb 24, 2023
Ford axle recall — NHTSA campaign 23V128000
Ford Motor Company (Ford) is recalling certain 2023 F-150, Expedition, and Lincoln Navigator vehicles. The front axle pinion may not have been heat-treated, which can cause it to fracture.
axleFord Motor Company
VehicleFeb 23, 2023
Chrysler clutch recall — NHTSA campaign 23V116000
Chrysler (FCA US, LLC) is recalling certain 2018-2023 Jeep Wrangler, and 2020-2023 Jeep Gladiator vehicles equipped with manual transmissions. The clutch pressure plate may overheat and…
clutchChrysler (FCA US, LLC)
DrugFeb 22, 2023
Metoprolol Succinate Extended-Release Tablets, USP, 50 mg recall — FDA D-0269-2023
Failed Dissolution Specifications: This recall is being initiated in support of the recall by the manufacturer which included lots that were packaged for BluePoint Laboratories.
Class IIFDA: TerminatedAmerisource Health Services LLC
DrugFeb 22, 2023
Sentara Infusion Services TPN (a) 115GM/AA, 215GM/DEX, 25GM/LIP 1150ML, (b)90GM/AA recall — FDA D-0320-2023
Lack of sterility assurance
Class IIFDA: TerminatedSentara Infusion Services
DrugFeb 22, 2023
Consolidated Chemical Techni-Care Chloroxylenold 3%, [4 fl oz /118 mL or 8 fl oz/236 mL] per recall — FDA D-0325-2023
CGMP Deviations: initiated due to violations of CGMP manufacturing practices
Class IIFDA: OngoingConsolidated Chemical, Inc.
Browse by month
Recent recall archives
Browse recent months with enough recall history for useful comparison.
August 2026149 records · 4 categoriesJuly 2026371 records · 4 categoriesJune 2026375 records · 4 categoriesMay 2026340 records · 4 categoriesApril 2026415 records · 4 categoriesMarch 2026190 records · 4 categoriesFebruary 2026331 records · 4 categoriesJanuary 2026212 records · 4 categoriesDecember 2025389 records · 4 categoriesNovember 2025326 records · 4 categoriesOctober 2025455 records · 4 categoriesSeptember 2025285 records · 4 categories